Andreas Reichel

4.3k total citations
88 papers, 2.6k citations indexed

About

Andreas Reichel is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Andreas Reichel has authored 88 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 24 papers in Molecular Biology and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Andreas Reichel's work include Drug Transport and Resistance Mechanisms (24 papers), Diabetes Management and Research (12 papers) and Computational Drug Discovery Methods (9 papers). Andreas Reichel is often cited by papers focused on Drug Transport and Resistance Mechanisms (24 papers), Diabetes Management and Research (12 papers) and Computational Drug Discovery Methods (9 papers). Andreas Reichel collaborates with scholars based in Germany, United Kingdom and United States. Andreas Reichel's co-authors include David J. Begley, Philip Lienau, N. Joan Abbott, Gert Fricker, Stefan R. Bornstein, Hannes Rietzsch, Andreas Barthel, Elena Tsourdi, Wilhelm Huisinga and Ben‐Fillippo Krippendorff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Andreas Reichel

85 papers receiving 2.5k citations

Peers

Andreas Reichel
Kevin R. Kozak United States
Péter Buchwald United States
Emidio Camaioni Italy
Italo Poggesi Italy
Xiaochao Ma United States
Antônio Barbieri Italy
James J. Cali United States
Kui Cheng China
Yumi Imai United States
Dan Chen China
Kevin R. Kozak United States
Andreas Reichel
Citations per year, relative to Andreas Reichel Andreas Reichel (= 1×) peers Kevin R. Kozak

Countries citing papers authored by Andreas Reichel

Since Specialization
Citations

This map shows the geographic impact of Andreas Reichel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Reichel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Reichel more than expected).

Fields of papers citing papers by Andreas Reichel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Reichel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Reichel. The network helps show where Andreas Reichel may publish in the future.

Co-authorship network of co-authors of Andreas Reichel

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Reichel. A scholar is included among the top collaborators of Andreas Reichel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Reichel. Andreas Reichel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reichel, Andreas, et al.. (2025). PK/PD modeling of targeted protein degraders: Charting new waters and navigating the shallows. Drug Discovery Today. 30(3). 104311–104311. 2 indexed citations
2.
Reichel, Andreas, et al.. (2024). Transforming the Discovery of Targeted Protein Degraders: The Translational Power of Predictive PK/PD Modeling. Clinical Pharmacology & Therapeutics. 116(3). 770–781. 5 indexed citations
3.
Lehr, Thorsten, et al.. (2024). Exploring the Potential of Adaptive, Local Machine Learning in Comparison to the Prediction Performance of Global Models: A Case Study from Bayer’s Caco-2 Permeability Database. Journal of Chemical Information and Modeling. 64(24). 9163–9172. 1 indexed citations
4.
Reichel, Andreas, et al.. (2023). A Mechanistic Pharmacodynamic Modeling Framework for the Assessment and Optimization of Proteolysis Targeting Chimeras (PROTACs). Pharmaceutics. 15(1). 195–195. 21 indexed citations
5.
Lechner, Christian, Ursula Mönning, Andreas Reichel, & Gert Fricker. (2021). Potential and Limits of Kidney Cells for Evaluation of Renal Excretion. Pharmaceuticals. 14(9). 908–908. 11 indexed citations
6.
7.
Ludwig, Barbara, Andreas Barthel, Andreas Reichel, et al.. (2014). Modulation of the Pancreatic Islet-Stress Axis as a Novel Potential Therapeutic Target in Diabetes Mellitus. Vitamins and hormones. 95. 195–222. 6 indexed citations
8.
Lechner, Christian, et al.. (2010). Development of a fluorescence-based assay for drug interactions with human Multidrug Resistance Related Protein (MRP2; ABCC2) in MDCKII-MRP2 membrane vesicles. European Journal of Pharmaceutics and Biopharmaceutics. 75(2). 284–290. 20 indexed citations
9.
Krippendorff, Ben‐Fillippo, Roland Neuhaus, Philip Lienau, Andreas Reichel, & Wilhelm Huisinga. (2009). Mechanism-Based Inhibition: Deriving KI and kinact Directly from Time-Dependent IC50 Values. SLAS DISCOVERY. 14(8). 913–923. 109 indexed citations
10.
11.
Reichel, Andreas, et al.. (2008). Characterization of Cytochrome P450 Protein Expression along the Entire Length of the Intestine of Male and Female Rats. Drug Metabolism and Disposition. 36(6). 1039–1045. 55 indexed citations
12.
Thierauch, Karl‐Heinz, Martin Haberey, Holger Hess‐Stumpp, et al.. (2007). ZK 261991. a novel VEGFR inhibitor for tumor therapy. Cancer Research. 67. 2135–2135. 1 indexed citations
13.
Reichel, Andreas. (2006). The Role of Blood-Brain Barrier Studies in the Pharmaceutical Industry. Current Drug Metabolism. 7(2). 183–203. 108 indexed citations
14.
Krippendorff, Ben‐Fillippo, Philip Lienau, Andreas Reichel, & Wilhelm Huisinga. (2006). Optimizing Classification of Drug-Drug Interaction Potential for CYP450 Isoenzyme Inhibition Assays in Early Drug Discovery. SLAS DISCOVERY. 12(1). 92–99. 41 indexed citations
15.
Chishty, Mansoor, David J. Begley, N. Joan Abbott, & Andreas Reichel. (2004). Interaction of Nucleoside Analogues with Nucleoside Transporters in Rat Brain Endothelial Cells. Journal of drug targeting. 12(5). 265–272. 12 indexed citations
16.
Chishty, Mansoor, et al.. (2003). Functional characterisation of nucleoside transport in rat brain endothelial cells. Neuroreport. 14(7). 1087–1090. 24 indexed citations
17.
Reichel, Andreas & David J. Begley. (1998). Potential of Immobilized Artificial Membranes for Predicting Drug Penetration Across the Blood−Brain Barrier. Pharmaceutical Research. 15(8). 1270–1274. 94 indexed citations
18.
19.
Begley, David J., Andreas Reichel, & A. Ermisch. (1994). Simple high-performance liquid chromatographic analysis of free primary amino acid concentrations in rat plasma and cisternal cerebrospinal fluid. Journal of Chromatography B Biomedical Sciences and Applications. 657(1). 185–191. 24 indexed citations
20.
Reichel, Andreas & Joachim Behlke. (1968). [On lymph proteins of Rana esculenta].. PubMed. 116(2). 158–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin R. Kozak Breakdown of academic impact, for papers by Péter Buchwald Breakdown of academic impact, for papers by Emidio Camaioni Breakdown of academic impact, for papers by Italo Poggesi Breakdown of academic impact, for papers by Xiaochao Ma Breakdown of academic impact, for papers by Antônio Barbieri Breakdown of academic impact, for papers by James J. Cali Breakdown of academic impact, for papers by Kui Cheng Breakdown of academic impact, for papers by Yumi Imai Breakdown of academic impact, for papers by Dan Chen
Rankless by CCL
2026